Travelers Adds $295 Million To Asbestos Reserves, Though Open-Claim Policyholders Are Flat
The 10-Q ties the third-quarter charge to higher payments, not more policyholders with open claims.
Travelers added $295 million to its net asbestos reserves in the third quarter, against $277 million a year earlier, its 10-Q filed Friday shows. The same filing describes the count of policyholders with open asbestos claims as "relatively flat" versus 2025, so the driver is what the company is paying, not how many are claiming.
The finding: higher payments, flat policyholder count
The 10-Q says the reserve increases were primarily driven by a higher estimate of projected settlement and defense costs across a broad number of policyholders. Travelers blames payments running above earlier expectations, pointing to persistently heavy mesothelioma filings and the present litigation climate around them.
Government data show mesothelioma deaths still trending down. Net asbestos payments were $215 million for the first nine months of 2026, against $171 million in the same period of 2025.
Net asbestos reserves stood at $1.44 billion at September 30, 2026, against $1.45 billion a year earlier. The prior quarterly filing put them at $1.22 billion at June 30, 2026.
The catch: a charge inside larger favorable development
The asbestos addition is embedded in $234 million of favorable net prior-year reserve development for the quarter, up from $22 million a year earlier. The 10-Q says Business Insurance's $41 million of favorable development came from better-than-expected loss experience in all major product lines, partly offset by the $295 million asbestos addition.
The reserve figure is also a net number. Gross asbestos reserves were $1.81 billion at September 30, 2026, before $376 million of reinsurance recoverables are netted out, the filing's reserve table shows. Gross paid losses for the nine months were $265 million; the net figure was $215 million.
The addition follows the annual in-depth claim review, which the company completed in the third quarter of 2026 and says it also did in 2025.
Who it touches
For holders, the charge reduced the benefit of favorable development elsewhere in a quarter when net income was $1.92 billion, up 2% from $1.89 billion, and diluted earnings per share were $9.04, up 10% from $8.24.
The company's assessment of the underlying asbestos environment is "essentially unchanged from recent periods," and it says there remains a high degree of uncertainty about future exposure. It adds that additional liabilities beyond current reserves could arise and could be material to results in future periods. Management also says it believes the reserves are appropriately established.
The next annual in-depth asbestos review falls in the third quarter of 2027, and the fourth-quarter annual report will show whether net payments keep outrunning last year's pace.
